Vivos Inc (RDGL)

[SC8]

I'm less concerned about the dilution to get there and more concerned with the slow progress because we have little to no market FOMO on RDGL to date. If I understand correctly, game plan (once and if RDGL raises the $) is to start with superficial treatment of human skin cancer trials where there are already a myriad of effective treatments. The big game changer is adding this treatment option to internal tumors, and that seems many years, many trials and mui mucho $ away.